ETF Opportunities Trust has announced a post-effective amendment to its registration statement, which will designate November 20, 2026, as the new effective date for its funds. This filing is crucial as it reflects the company's ongoing commitment to its investment strategies and regulatory compliance.
ETF Opportunities Trust is an investment company based in Richmond, Virginia. The company is registered under the Investment Company Act of 1940 and focuses on managing various exchange-traded funds (ETFs). Its recent filings include multiple amendments and updates aimed at enhancing its investment offerings.
According to the filing dated November 5, 2026, the amendment is filed under Rule 485(b)(1)(iii) for the sole purpose of establishing the new effective date for previously filed amendments. The filing states, "This post-effective amendment designates a new effective date for a previously filed post-effective amendment." The funds involved include the T-REX 2X LONG AGLT DAILY TARGET ETF, T-REX 2X LONG RUN DAILY TARGET ETF, T-REX 2X LONG SEDG DAILY TARGET ETF, T-REX 2X INVERSE MRVL DAILY TARGET ETF, and T-REX 2X INVERSE SKHY DAILY TARGET ETF.
This update may affect investors and stakeholders within the investment management sector. By designating a new effective date, ETF Opportunities Trust aims to ensure that its funds are compliant with regulatory requirements and continue to meet investor expectations. The filing may prompt competitors to reassess their strategies in the rapidly evolving ETF market.
As for what’s next, the filing does not specify any further actions or upcoming filings related to this amendment. Investors and industry observers will be watching closely to see how this change impacts ETF Opportunities Trust's performance and its competitive positioning in the market.
Read Next
ETF Opportunities Trust Sets New Effective Date for Funds
Howley W Nicholas Reports Stock Option Transaction
TransDigm director exercises stock options worth $708,000
TransDigm director Michael Graff exercises stock options
Federico Richard D acquires shares in Allient Inc.
TransDigm director Sean Hennessy exercises stock options










